Design, Synthesis, and Biological Evaluation of Novel Pyrrolo [2,3-b] Pyridine Derivatives for Nonalcoholic Fatty Liver Disease

<div>H&amp;E staining of the mouse liver of model (model group) and vehicle (vehicle group). F-9 (10) (F-9, 10 mg/kg), F-9 (50) (F-9, 50 mg/kg), F-15 (10) (F-15, 10 mg/kg), and F-15 (50) (F-15, 50 mg/kg)).</div>

Journal of Chemistry

fig5

Figure 5

Figure 5: Design, Synthesis, and Biological Evaluation of Novel Pyrrolo [2,3-b] Pyridine Derivatives for Nonalcoholic Fatty Liver Disease 